|
HS Code |
232636 |
| Chemical Name | Vincamine |
| Cas Number | 1617-90-9 |
| Molecular Formula | C21H26N2O3 |
| Molecular Weight | 354.44 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Slightly soluble in water, soluble in ethanol |
| Melting Point | 146-148°C |
| Source | Alkaloid derived from Vinca minor (Lesser Periwinkle) |
| Pharmacological Use | Cerebral vasodilator |
| Storage Conditions | Store in a cool, dry place away from light |
| Synonyms | Eburnamonine, Vincamone |
| Route Of Administration | Oral |
| Stability | Stable under recommended storage conditions |
| Bioavailability | Approximately 20% |
| Atc Code | C04AE02 |
As an accredited Vincamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Vincamine is packaged in a sealed, amber glass bottle containing 25 grams of fine white powder, labeled with safety and handling instructions. |
| Shipping | Vincamine is shipped in tightly sealed, chemical-resistant containers, protected from light and moisture. It is typically transported at room temperature, following all safety and regulatory guidelines for pharmaceutical and laboratory chemicals. Proper labeling and documentation are included to ensure compliance with international shipping standards and to safeguard handlers during transit. |
| Storage | Vincamine should be stored in a tightly closed container, protected from light and moisture. It should be kept at room temperature, ideally between 20–25°C (68–77°F). The storage area should be well-ventilated and away from incompatible substances, such as strong oxidizers. Proper labeling and secure containment are important to ensure safety and maintain the chemical’s stability. |
|
Purity 99%: Vincamine of 99% purity is used in pharmaceutical tablet formulations, where high purity ensures consistent therapeutic efficacy. Melting Point 148°C: Vincamine with a melting point of 148°C is used in controlled-release drug delivery systems, where thermal stability supports precise release kinetics. Particle Size ≤10 µm: Vincamine with particle size ≤10 µm is used in oral suspensions, where fine dispersion improves bioavailability. Molecular Weight 354.45 g/mol: Vincamine with a molecular weight of 354.45 g/mol is utilized in IV infusion solutions, where defined molecular mass allows for accurate dosage calculation. Stability Temperature up to 40°C: Vincamine stable up to 40°C is used in ambient storage conditions, where thermal stability maintains product potency. Optical Rotation +65°: Vincamine with optical rotation +65° is used in enantiomerically pure formulations, where chiral specificity enhances pharmacological activity. Moisture Content ≤1%: Vincamine with ≤1% moisture content is applied in lyophilized injectable products, where low moisture increases shelf-life and stability. Solubility in Ethanol 15 mg/mL: Vincamine with solubility of 15 mg/mL in ethanol is used in liquid extract preparations, where solubility enables high-concentration formulations. Impurity Level <0.2%: Vincamine with impurity level below 0.2% is used in neuroprotective supplements, where low impurity minimizes adverse reactions. Ash Content ≤0.3%: Vincamine with ash content ≤0.3% is used in nutraceutical capsules, where minimal inorganic residue improves product safety. |
Competitive Vincamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Vincamine often turns up in conversations about brain health and cognitive support, but the details behind this product can easily get lost among buzzwords and sales talk. As someone who has followed the evolution of nootropic supplements for years and studied their real-world effects, I want to lay out what sets Vincamine apart—both on the shelf and after it’s in your hands.
Vincamine is a naturally-derived compound extracted from the leaves of Vinca minor, commonly called the lesser periwinkle. It doesn’t present itself with flashy branding or trend-driven additives; its central appeal lies in decades of research and its straightforward approach to cognitive support. Unlike a cocktail of synthetic ingredients blended together to target a laundry list of symptoms, Vincamine sticks to what it knows best—helping improve blood flow to the brain.
The product typically comes in capsule or tablet form, each containing a dose ranging from 5 mg to 30 mg. Some brands offer pure Vincamine, while others blend it with co-factors like magnesium or B vitamins. The ingredient label stays short, and you can usually trace the manufacturing back to facilities that emphasize quality control. This transparency builds trust for people wary of hidden fillers or questionably sourced herbal extracts.
For people interested in keeping their mind sharp, Vincamine carries weight mostly because of its potential to increase cerebral blood flow. Research dating back to the 1970s found that this alkaloid works as a vasodilator. In simple terms, it relaxes blood vessels, making it easier for oxygen and nutrients to reach neural tissue. While some supplements make big promises without much science behind them, Vincamine has appeared in numerous clinical trials, particularly in Europe, with outcomes measured in memory, attention, and even cases related to age-associated cognitive changes.
I remember seeing Vincamine’s impact in academic settings: students prepping for exams, older adults expressing frustration over mental fog, or professionals chasing a productivity edge. Consistency matters more than instant results—few people report sudden, dramatic changes; instead, improvements tend to come as a steady sharpening of focus and mental stamina.
People often ask how Vincamine compares to wildly popular options like Ginkgo biloba, Bacopa monnieri, or synthetic compounds such as Piracetam. Unlike Ginkgo, which has mixed evidence behind it, Vincamine’s studies highlight its selective role as a vasodilator. While Bacopa tends to lean on its antioxidant capacity, Vincamine addresses cerebral perfusion directly. Piracetam, another regular on “smart pill” lists, operates primarily via neurotransmitter modification and cell membrane fluidity, not vascular action.
Talking with people who have switched from broader-spectrum formulas to single-ingredient Vincamine, many notice less jitteriness and a more predictable onset. Side effect profiles matter, especially to anyone using nootropics for extended periods. Stimulant-heavy blends may bring crashes, while Vincamine avoids that rollercoaster by sidestepping pathways linked to excess dopamine or adrenaline. This gives Vincamine a distinct appeal to people who want steady support instead of peaks and valleys.
While anyone can walk into a supplement store or shop online for Vincamine, the typical user skews older—often over 40—seeking help with mild forgetfulness, attention lapses, or word-finding trouble that creeps in with age. Younger people, battling high-pressure workloads or cramming for exams, reach for it hoping for an edge, but the largest demand still comes from an aging population prioritizing mental clarity and independence.
Dosage recommendations usually fall in the 10 mg to 30 mg daily range. Some physicians in Europe have prescribed it off-label for vascular dementia or circulation issues. Outside clinical supervision, people tend to start low and build up, paying close attention to results and any unwanted effects. Because Vincamine can interact with blood pressure medication or anticoagulants, consulting a doctor remains not just wise, but necessary for anyone managing multiple prescriptions. Skipping this step has led to avoidable problems—especially in communities where supplement oversight stays lax and online advice fills the void left by evidence-based guidance.
Vincamine’s roots go deep in European medicine cabinets. Years ago I traveled in France and saw how doctors there considered Vincamine for patients with early-stage dementia or those recovering from strokes, especially if vascular risk factors played a role. Journals like Drugs & Aging and International Journal of Clinical Practice have covered its potential benefits, often noting improvements in processing speed and recall in those with pre-existing neurovascular issues.
Diving into the research, the biggest impact often surfaces in populations with a tangible reduction in brain perfusion. Instead of attempting to “boost” healthy brains beyond their normal capacity, Vincamine aims to restore flow in cases where arteries have narrowed or blood pressure drops cause dizziness and confusion. You won’t find wild claims about IQ jumps or instant photographic memory; instead, the outcomes revolve around daily functions—remembering appointments, finding the right words in conversation, or keeping track of a bill at the grocery store.
No supplement scene escapes the rogue’s gallery of mystery blends, poor lab practices, and unreal claims. Vincamine generally fares better than the average herbal supplement because many producers operate under stricter international standards—especially respected firms in Europe and Japan. I always tell people to watch for third-party certification or analytical data on heavy metals and adulterants. Without those tests, purity gets hard to guarantee, and risk grows for populations already dealing with heart or brain conditions.
An informed buyer asks for lot numbers, expiry dates, and country of origin. Investigating these basics headed off more than one near-miss in my own circle. In some cases, independent labs have flagged products for containing traces of vincamine’s analog vinpocetine instead, which, though related, differs noticeably in absorption rates and metabolism. This transparency gap led regulators in several countries to clamp down, limiting or banning related compounds until clear safety data emerged. Vincamine’s place on the shelf holds steady thanks to its longer record of use and a safety profile that, while not perfect, stands far above most “latest and greatest” nootropics hunted for their online buzz.
While supplements rarely trigger headlines for medical emergencies, Vincamine isn’t a fit for everyone. Side effects like low blood pressure, digestive upset, or sleep disturbance crop up occasionally. Drug interactions top the list of concerns, especially for anyone already on antihypertensives or anticoagulant therapy. In my experience, frank conversation with a trusted doctor remains the best defense against unwanted surprises. Those conversations matter most for people managing heart arrhythmias, migraines, or balance issues, where blood flow tweaks can rewrite risk equations in a hurry.
The supplement world sometimes attracts wishful thinking—hopes for a magic pill that erases decades of wear and tear. Vincamine doesn’t wear that cape. Instead, it can serve as one tool among many, working best in the context of good sleep, exercise, and regular engagement with mentally challenging activities. That framework fits with current consensus in neurology circles and fits real stories from people who saw improvement only after committing to a broader lifestyle overhaul.
Walking through the regulatory maze usually feels daunting. In the United States, Vincamine falls under the loose regulation umbrella of the Dietary Supplement Health and Education Act. That leaves enforcement in the hands of companies, not the FDA, unless hazards emerge or the label claims veer into drug territory. Europe takes a more conservative stance—several countries require proof of standardization, label accuracy, and adverse event reporting. Over the past decade, I’ve talked to pharmacists and importers who see a clear divide between products meant for domestic European markets and those aimed at under-regulated international online customers.
The lesson: don’t shop blind. Customer reviews, while helpful, replace neither transparent ingredient sourcing nor robust certification. In communities with easy access to reputable pharmacies and health care providers, Vincamine use stays safer and better informed. For those ordering online from unknown suppliers, risk climbs—especially when companies emphasize one-size-fits-all formulas, ignore expiration dates, or dodge independent lab tests.
Supplement culture has grown from niche health food store counters to sprawling online outlets. I see this shift in demand play out at community pharmacies, on college campuses, and in elder care centers. While the desire for sharp thinking connects us, expectations set by heavily marketed “brain boosters” can crowd out measured discussion about what products like Vincamine actually offer.
Confusion grows when supplements like Vincamine appear next to high-stimulation amphetamines or anxiety-soothing herbs. The temptation to stack products, hoping for stronger results, often follows marketing more than science. In lived experience, most people see the clearest benefit from consistency, safety, and honest goal-setting—rather than quick fixes or wild combinations.
This dynamic affects both individuals and health care systems. As more people seek help outside the traditional medical model, the quality and accessibility of information matter more. Doctors, dietitians, and researchers need to step up, not only by reporting side effects but also by sharing case studies and practical guidance for long-term users. That bridge helps replace confusing Internet chatter with practical know-how.
Building a safer, more transparent market for Vincamine and similar supplements requires buy-in from multiple angles: stricter quality standards, accessible consumer education, and open communication between health care providers and their patients. After talking with health leaders in different communities, I saw two big wins emerge—standardizing labels, and increasing public access to independent testing results. This approach builds trust and puts power in the hands of everyday buyers instead of just manufacturers.
Policy shifts need advocacy. Communities can pressure retailers to stock only products with known origins and reliable test data. Partnering with pharmacists and clinicians allows for public workshops, where the nuances of supplement use can be broken down for those unfamiliar with either the promised risks or potential consequences. That sort of education lessens the risks of self-prescribing, especially among older adults or people with chronic disease, where interactions can easily shift from minor annoyance to serious harm.
Years of working in health communication taught me that curiosity, not hype, brings about the most useful change. Vincamine, with its roots in both traditional herbalism and modern clinical research, stands as a useful example of what can happen when communities value evidence as much as tradition. While people continue to search for ways to protect their brains from aging, stress, and the chaos of daily life, Vincamine offers a reminder that steady, transparent, and modestly-claimed tools often work best—especially when used with respect for the body’s real needs and limits.
Society stands at a crossroads, balancing enthusiasm for “hacking” human performance against real risks of misuse. As research continues and people ask better questions, the story of Vincamine will likely shift with new discoveries and tighter regulations. What remains most important is not the promise of transformation, but the everyday knowledge needed to make safe, informed choices—choices that respect both scientific expertise and the lived complexity of keeping a mind sharp throughout each stage of life.
In a landscape that encourages chasing after the next big thing, Vincamine reminds us that value lies in trusted processes, proven outcomes, and clear communication. Its steady role in supporting brain health won’t turn heads with dramatic announcements, but its persistence in people’s routines speaks volumes about the enduring power of thoughtful, patient care for both body and mind.